BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nia A, Dhanasekaran R. Genomic Landscape of HCC. Curr Hepatol Rep 2020;19:448-61. [PMID: 33816052 DOI: 10.1007/s11901-020-00553-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Jiang C, Liu Z, Yuan J, Wu Z, Kong L, Yang J, Lv T. Construction of Two Independent RAB Family-Based Scoring Systems Based on Machine Learning Algorithms and Definition of RAB13 as a Novel Therapeutic Target for Hepatocellular Carcinoma. Int J Mol Sci 2023;24. [PMID: 36901767 DOI: 10.3390/ijms24054335] [Reference Citation Analysis]
2 Badwei N. Hepatocellular carcinoma gene expression: The New Era, Where It Goes? iLIVER 2022. [DOI: 10.1016/j.iliver.2022.12.001] [Reference Citation Analysis]
3 Tang Y, Zhang Y, Zhong T, Huai R, Guo Z. Identification and function of TEAD1 regulated enhancer in HepG2 cells.. [DOI: 10.21203/rs.3.rs-2128403/v1] [Reference Citation Analysis]
4 Pu J, Qin Z, Fang Q, Huang Y, Lu Y, Li W, Wang J, Tang Q, Zeng D, Wei H. Hypoxia-induced HIF1A Activates DUSP18-mediated MAPK14 Dephosphorylation to Promote Hepatocellular Carcinoma Cell Migration and Invasion. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153955] [Reference Citation Analysis]
5 Adeniji N, Dhanasekaran R. Current and Emerging Tools for Hepatocellular Carcinoma Surveillance. Hepatol Commun 2021. [PMID: 34533885 DOI: 10.1002/hep4.1823] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
6 Wang J, Liu R, Zhao Y, Ma Z, Sang Z, Wen Z, Yang X, Xie H. Novel Microcrystal Formulations of Sorafenib Facilitate a Long-Acting Antitumor Effect and Relieve Treatment Side Effects as Observed With Fundus Microcirculation Imaging. Front Oncol 2021;11:743055. [PMID: 34513717 DOI: 10.3389/fonc.2021.743055] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
7 Woller N, Engelskircher SA, Wirth T, Wedemeyer H. Prospects and Challenges for T Cell-Based Therapies of HCC. Cells 2021;10:1651. [PMID: 34209393 DOI: 10.3390/cells10071651] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
8 Raees A, Kamran M, Özkan H, Jafri W. Updates on the Diagnosis and Management of Hepatocellular Carcinoma. Euroasian J Hepatogastroenterol 2021;11:32-40. [PMID: 34316462 DOI: 10.5005/jp-journals-10018-1335] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]